StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.46−0.28 (-3.20%)

Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –

MeiraGTx r&d expenses

Research and development expenses are spending on new products and technology.

MeiraGTx's R&D Expenses for the twelve months ending Jun 30, 2026 was $153.16M, up 31.5% year over year. For fiscal 2025 it was $129.62M, up 8.5% from the year before. The highest annual figure on record is $129.62M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$129.62M+8.5%
FY2024Dec 31, 2024$119.48M+15.1%
FY2023Dec 31, 2023$103.79M+21.1%
FY2022Dec 31, 2022$85.73M+28.5%
FY2021Dec 31, 2021$66.69M+96.7%
FY2020Dec 31, 2020$33.91M+36.3%
FY2019Dec 31, 2019$24.88M-26.0%
FY2018Dec 31, 2018$33.62M+50.4%
FY2017Dec 31, 2017$22.36M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$57.83M+72.7%
Q1 FY2026Mar 31, 2026$31.98M-2.4%
Q4 FY2025Dec 31, 2025$30.81M+28.5%
Q3 FY2025Sep 30, 2025$32.53M+24.0%
Q2 FY2025Jun 30, 2025$33.50M-4.1%
Q1 FY2025Mar 31, 2025$32.78M-4.5%
Q4 FY2024Dec 31, 2024$23.99M-28.8%
Q3 FY2024Sep 30, 2024$26.24M-5.8%
Q2 FY2024Jun 30, 2024$34.93M+75.2%
Q1 FY2024Mar 31, 2024$34.32M+53.8%
Q4 FY2023Dec 31, 2023$33.67M+54.7%
Q3 FY2023Sep 30, 2023$27.86M+65.2%
Q2 FY2023Jun 30, 2023$19.94M-16.9%
Q1 FY2023Mar 31, 2023$22.32M-3.4%
Q4 FY2022Dec 31, 2022$21.77M+65.1%
Q3 FY2022Sep 30, 2022$16.86M-22.0%
Q2 FY2022Jun 30, 2022$24.00M+58.0%
Q1 FY2022Mar 31, 2022$23.10M+38.2%
Q4 FY2021Dec 31, 2021$13.18M+163.7%
Q3 FY2021Sep 30, 2021$21.61M+367.2%
Q2 FY2021Jun 30, 2021$15.19M-6.2%
Q1 FY2021Mar 31, 2021$16.71M+106.7%
Q4 FY2020Dec 31, 2020$5.00M+8.3%
Q3 FY2020Sep 30, 2020$4.63M-52.7%
Q2 FY2020Jun 30, 2020$16.20M+24.9%
Q1 FY2020Mar 31, 2020$8.08M-25.1%
Q3 FY2019Sep 30, 2019$4.61M-43.1%
Q2 FY2019Jun 30, 2019$9.77M+25.4%
Q1 FY2019Mar 31, 2019$12.98M+87.3%
Q4 FY2018Dec 31, 2018$10.79M+86.6%
Q3 FY2018Sep 30, 2018$8.11M+26.9%
Q2 FY2018Jun 30, 2018$7.79M+45.3%
Q1 FY2018Mar 31, 2018$6.93M–
Q4 FY2017Dec 31, 2017$5.78M–
Q3 FY2017Sep 30, 2017$6.39M–
Q2 FY2017Jun 30, 2017$5.36M–

More MeiraGTx figures

See a number that looks wrong?